Turpin G, Heshmati H M, Zygelman N, Van Effenterre R, Gaham N, De Gennes J L
Ann Med Interne (Paris). 1982;133(1):35-7.
Therapeutic results in 80 cases of pituitary prolactin adenomas, grouped according to Hardy's neurosurgical classification, are discussed as a function of the 5 types of treatment administered. These were: selective adenomectomy by the trans-sphenoidal approach under microscopic supervision; bromocriptine usually at doses of 5 to 7.5 mg per day; combined surgery and radiotherapy (50 to 60 grays 5 times per week for 5 to 6 weeks); surgery plus bromocriptine; surgery plus radiotherapy plus bromocriptine. Selective adenomectomy gives excellent results in stages 1 and 2, if performed by an experienced surgeon. Bromocriptine was remarkably effective in all cases, whatever the level of blood prolactin and the size of the adenoma. Prolactin levels never returned to normal after radiotherapy, which also markedly increased the frequency of post-therapeutic hormonal insufficiencies.
根据哈代神经外科分类法对80例垂体泌乳素腺瘤患者进行分组,讨论了所采用的5种治疗方法的治疗效果。这5种治疗方法分别是:在显微镜监测下经蝶窦入路进行选择性腺瘤切除术;溴隐亭,通常每日剂量为5至7.5毫克;手术与放疗联合治疗(每周5次,每次50至60戈瑞,共5至6周);手术加溴隐亭;手术加放疗加溴隐亭。如果由经验丰富的外科医生进行手术,选择性腺瘤切除术在1期和2期能取得极佳效果。溴隐亭在所有病例中均有显著疗效,无论血泌乳素水平和腺瘤大小如何。放疗后泌乳素水平从未恢复正常,且放疗还显著增加了治疗后激素不足的发生率。